DFK Richard Hill is pleased to announce the successful ASX listing of Star Combo Pharma Ltd on 16 May 2018. The Company raised $12 million and has a market capitalisation of circa $120 million.
DFK Richard Hill was retained to manage the IPO process including the transition from private to listed company.
DFK Richard Hill will provide key ongoing services of external CFO and Company Secretary.
As previously noted, DFK Richard Hill has led the process for the sale of a client medical disbursement business, Macquarie Medico Legal, to an ASX listed company for circa $22 million, being a combination of shares and cash. The client became the largest shareholder of the listed company. The assignment included consideration of all of the tax exemption issues relating to scrip rollover.
Effective 1st January 2018, DFK Richard Hill’s private wealth arm has been reconstructed into a Joint Venture with Wealth Partners, https://www.wealthpartners.net.au, a well established significant practice in Milson’s Point.
The Joint Venture will provide significantly increased sophistication in portfolio selection and management as well as an increased focus on Self Managed Super Funds (SMSF’s) for DFK Richard Hill clients.